GIOVANI TWIGGE - 03 Aug 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Signature
/s/ Lily J. Lu, Attorney-in-Fact for Giovani Twigge
Issuer symbol
IDXX
Transactions as of
03 Aug 2021
Net transactions value
-$10,716,207
Form type
4
Filing time
05 Aug 2021, 17:02:21 UTC
Next filing
16 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $100,147 +1,476 +8.7% $67.85 18,447 03 Aug 2021 Direct F1
transaction IDXX Common Stock Options Exercise $1,256,558 +8,874 +48% $141.60 27,321 03 Aug 2021 Direct
transaction IDXX Common Stock Sale $4,892,395 -7,036 -26% $695.34 20,285 03 Aug 2021 Direct F2
transaction IDXX Common Stock Sale $1,279,837 -1,838 -9.1% $696.32 18,447 03 Aug 2021 Direct F3
transaction IDXX Common Stock Options Exercise $916,435 +5,141 +28% $178.26 23,588 04 Aug 2021 Direct
transaction IDXX Common Stock Options Exercise $634,892 +3,068 +13% $206.94 26,656 04 Aug 2021 Direct
transaction IDXX Common Stock Options Exercise $546,661 +1,893 +7.1% $288.78 28,549 04 Aug 2021 Direct
transaction IDXX Common Stock Sale $923,300 -1,319 -4.6% $700.00 27,230 04 Aug 2021 Direct
transaction IDXX Common Stock Sale $6,472,198 -9,242 -34% $700.30 17,988 04 Aug 2021 Direct F4
transaction IDXX Common Stock Sale $603,170 -860 -4.8% $701.36 17,128 04 Aug 2021 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise -1,476 -100% 0 03 Aug 2021 Common Stock 1,476 $67.85 Direct F6, F11
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -8,874 -85% 1,512 03 Aug 2021 Common Stock 8,874 $141.60 Direct F7, F11
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -5,141 -64% 2,866 04 Aug 2021 Common Stock 5,141 $178.26 Direct F8, F11
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -3,068 -43% 4,118 04 Aug 2021 Common Stock 3,068 $206.94 Direct F9, F11
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -1,893 -25% 5,677 04 Aug 2021 Common Stock 1,893 $288.78 Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 21.4780 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
F2 Represents the weighted average price of the shares sold ranging from a low of $695.00 to a high of $695.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Represents the weighted average price of the shares sold ranging from a low of $696.02 to a high of $696.78 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F4 Represents the weighted average price of the shares sold ranging from a low of $700.00 to a high of $700.995 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F5 Represents the weighted average price of the shares sold ranging from a low of $701.05 to a high of $701.91 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F6 Grant of option to buy 1,476 shares of Issuer common stock that vested as to 1 share on February 14, 2017, February 14, 2018 and February 14, 2020, respectively, and as to the remainder on February 14, 2021.
F7 Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018.
F8 Grant of option to buy 8,007 shares of Issuer common stock that vest in five annual installments beginning February 14, 2019.
F9 Grant of option to buy 7,186 shares of Issuer common stock that vest in four annual installments beginning February 14, 2020.
F10 Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
F11 Not applicable.